JRC scientists, in collaboration with University La Sapienza in Rome, tested the in vitro biocompatibility and internalisation efficiency of new effective nano drug delivery systems (niosomal nanocarriers) developed for future brain cancer therapies. The results revealed biocompatibility of formulations and efficient cellular uptake.
Further information: Nanocarriers for brain cancer therapy